Baird Medical Sponsors MGH Thyroid and Parathyroid Surgery Course

Rhea-AI Summary

Baird Medical (NASDAQ: BDMD) sponsored the Surgery of the Thyroid and Parathyroid Glands Course at Massachusetts General Hospital. The event featured discussions on thyroid and parathyroid surgery advancements, with Dr. Shuhang Xu presenting on microwave ablation (MWA) technology for treating thyroid conditions. The presentation highlighted MWA's benefits, including minimally invasive approach, shorter procedures, and precise ablation capabilities. The course covered upcoming American Thyroid Association guidelines and innovations in thyroid cancer management.

NEW YORK, Nov. 18, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leader in minimally invasive microwave ablation (MWA) technology, proudly sponsored the Surgery of the Thyroid and Parathyroid Glands Course, hosted by Massachusetts General Hospital (MGH), a teaching hospital affiliated with Harvard Medical School. This esteemed event, held in Boston, MA, brought together leading experts to discuss advancements in thyroid and parathyroid surgery, including updates in ablative technologies and evolving treatment guidelines.

A key highlight of the event was a panel debate on thermal ablation technologies, where Dr. Shuhang Xu presented on MWA as a promising option for treating thyroid nodules and cancer. His presentation emphasized the advantages of MWA, including its minimally invasive approach, shorter procedure times, and precise ablation capabilities, reflecting its growing adoption in modern thyroid care.

The course also explored updates to the forthcoming American Thyroid Association (ATA) guidelines, advancements in advanced thyroid cancer management, and a range of surgical innovations shaping the field.

By sponsoring this event, Baird Medical reaffirms its dedication to advancing education and collaboration within the medical community. As a pioneer in thermal ablation technology, Baird Medical remains committed to supporting healthcare professionals with innovative solutions for thyroid and parathyroid treatment.

About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visit https://bairdmed.com/

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/baird-medical-sponsors-mgh-thyroid-and-parathyroid-surgery-course-302308047.html

SOURCE BDMD

FAQ

What was the main focus of Baird Medical's (BDMD) sponsored course at MGH in November 2024?

The course focused on thyroid and parathyroid surgery advancements, including discussions on thermal ablation technologies and updates to treatment guidelines, with specific emphasis on microwave ablation (MWA) technology.

What are the key benefits of microwave ablation technology presented by Baird Medical (BDMD) at the MGH course?

The key benefits presented include minimally invasive approach, shorter procedure times, and precise ablation capabilities for treating thyroid nodules and cancer.

Where and when did Baird Medical (BDMD) sponsor the thyroid surgery course?

The course was held in Boston, MA at Massachusetts General Hospital (MGH) in November 2024.